Revisiting the Antigen 85 Complex as a Target for Functional Antibody-Based Strategies Against Mycobacterium

Izat Smekenov1,2, Nazym Tleumbetova1,2,3, Sagit Bektassov4

  • 1Department of Molecular Biology and Genetics, Faculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.

Microorganisms
|May 4, 2026
PubMed
Summary

Nanobodies offer a novel strategy to target the antigen 85 (Ag85) complex in Mycobacterium tuberculosis. These engineered antibodies can disrupt cell wall synthesis, potentially sensitizing bacteria to antibiotics.